2018

2018 (5)

Therachon AG, a clinical-stage biotechnology company focused on rare diseases, announced the start of "Dreambird", a natural history study of children with achondroplasia, the most common form of dysproportionate short stature in humans.

ENYO Pharma, a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions, today announced that it has completed a €40 million Series B round of financing from US and European investors

2018

La société BIOMODEX, société de dispositifs médicaux basée à Paris (FR) et Boston (US) conclut un tour de table de 12M€ ($15M) auprès d’Idinvest Partners (Lead), d’InnovAllianz, et de ses actionnaires historiques LBO France et Inserm Transfert Initiative.

L'édition 2018 de la conférence mettra à l'honneur les candidats médicaments et les approches de dépistage de la société en matière de troubles de l'oreille interne.

BIOMODEX, a Paris-based medical device company, announced it has received an additional $15 million in Series A funding led by European investment firms Idinvest Partners and InnovAllianz. With the participation of pre-existing investors, LBO France and Inserm Transfert Initiative, BIOMODEX’s total financing is now more the $18.5 million.